ALS Clinical Trials in Chicago

Showing 21-40 of 69 trials

Impact of Sensory Electrical Stimulation on Sensation and Tremor

NCT06428526

The purpose of this study is to understand the acute, short-term and long-term impact of transcutaneous and/or percutaneous electrical stimulation with afferent-specific electrical stimulation (asES) on proprioception and fine motor control in the upper extremity. For this purpose, the researchers will use transcutaneous and/or percutaneous asES, high-density electromyography (HD-EMG), arm kinematic measurements, and standardized clinical assessments. This study will be conducted in healthy able-bodied individuals and patients with essential tremor (ET).

Essential TremorHealthy Individuals

Shirley Ryan AbilityLab40 participantsStarted Jan 2025

Chicago, Illinois, United States

No Longer Available2.2 miles

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

NCT06069934

Protocol PL101-ALS501: This EAP will provide access to pridopidine for up to 200 patients with ALS who are ineligible for clinical trials.

Amyotrophic Lateral Sclerosis

Prilenia

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +29 more locations

PreviousPage 2 of 4Next

Impact of Sensory Electrical Stimulation on Sensation and Tremor

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

ALS Trials in Other Cities

Intermediate Expanded Access Protocol CNMAu8.EAP04

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

Stepping to Understand Lower Limb Impairments in Bilateral Cerebral Palsy

Telehealth Implementation of Brain-Computer Interface

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

Phase 3 Extension Study of Dexpramipexole in ALS

Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility Challenges

Deep Phenotyping in Patients With ALS

A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Safety Study of XT-150 in Participants With ALS

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis

Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS

Arimoclomol in Amyotropic Lateral Sclerosis

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Other Conditions in Chicago